- 全部删除
您的购物车当前为空
Erenumab是一种全人单克隆抗体,作用于抑制降钙素基因相关肽(CGRP)受体,用于预防发作性偏头痛。

为众多的药物研发团队赋能,
让新药发现更简单!
Erenumab是一种全人单克隆抗体,作用于抑制降钙素基因相关肽(CGRP)受体,用于预防发作性偏头痛。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,820 | In stock | |
| 5 mg | ¥ 4,560 | In stock | |
| 10 mg | ¥ 6,780 | In stock | |
| 25 mg | ¥ 9,870 | In stock | |
| 50 mg | ¥ 13,600 | In stock | |
| 100 mg | ¥ 18,300 | In stock |
Erenumab 相关产品
| 产品描述 | Erenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks. |
| 别名 | 厄瑞努单抗, AMG-334 |
| 分子量 | 146.2 kDa |
| CAS No. | 1582205-90-0 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容